双阳性、单阳性与血清阴性类风湿关节炎对结局的影响
该回顾性人群研究纳入2003至2019年明尼苏达州南部1373例新发类风湿关节炎(RA)患者,分析双阳性、单阳性及血清阴性状态与影像学骨侵蚀、疾病复发和死亡的关系。结果显示双阳性者骨侵蚀和复发比例最高,仅RF阳性者死亡率较血清阴性者显著升高(aHR 2.18,95%CI 1.47-3.24)。
要点
- 双阳性RA患者一年内影像学骨侵蚀(31%)和复发(69%)比例最高。
- 仅RF阳性RA患者死亡率较血清阴性者升高逾两倍(aHR 2.18,95%CI 1.47-3.24)。
- 仅抗CCP阳性者骨侵蚀比例最低(13%),死亡率升高无统计学意义。
核心结论
- 仅RF阳性的RA患者较血清阴性者死亡率显著增加,RF阳性可能是需要药物治疗以降低死亡率的炎症指标。
研究设计与样本
- 回顾性、人群为基础的队列研究,纳入2003至2019年明尼苏达州南部符合RA诊断标准的1373例新发RA居民。
- 采用Cox模型校正年龄、性别、吸烟状态、RA发病年份和合并症。
主要发现
- 发病时37%为双阳性,13%仅抗CCP阳性,12%仅RF阳性,38%血清阴性。
- 发病前或一年内影像学骨侵蚀比例在双阳性组最高(31%),仅抗CCP阳性组最低(13%)。
- 发病一年内疾病复发在双阳性组为69%,仅抗CCP阳性组为51%。
- 仅RF阳性组死亡率较血清阴性组升高(aHR 2.18,95%CI 1.47-3.24)。
- 双阳性组死亡率升高(aHR 1.66,95%CI 1.21-2.28),仅抗CCP阳性组aHR 1.32(95%CI 0.83-2.11)。
临床怎么用
- 对仅RF阳性的RA患者应关注死亡风险,考虑积极药物治疗以控制炎症。
- 双阳性RA患者需警惕早期骨侵蚀和疾病复发,加强影像学监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to investigate the association between dual seropositive, single seropositive, and seronegative rheumatoid arthritis (RA) with radiographic erosions, disease flares, and death. METHODS: We performed a retrospective, population-based study of residents in Southern Minnesota with incident RA who fulfilled criteria for RA in 2003 to 2019. Radiographic erosions and flares were evaluated within one year of incident RA. All-cause mortality was obtained from medical records and death certificates. Cox models adjusted for age, sex, smoking status, year of incident RA, and comorbidities were used. RESULTS: The study included 1,373 patients with RA. At RA incidence, 37% were dual seropositive, 13% seropositive for anti-cyclic citrullinated protein (anti-CCP) only, 12% seropositive for rheumatoid factor (RF) only, and 38% seronegative. The highest proportion of radiographic erosions before or within one year of RA incidence was in the dual seropositive (31%) and lowest in those seropositive for anti-CCP only (13%). Flares occurred in 69% of the dual seropositive and 51% of the seropositive for anti-CCP only within the first year of RA incidence. Those seropositive for RF only had over a two-fold increase in mortality rates compared with the seronegatives (adjusted hazard ratio [aHR] 2.18, 95% confidence interval [CI] 1.47-3.24). In contrast, the dual seropositives had only a >50% increase in mortality rates (aHR 1.66, 95% CI 1.21-2.28), and those seropositive only for anti-CCP had a >30% increase in mortality rates (aHR 1.32, 95% CI 0.83-2.11). CONCLUSION: Patients with RA seropositive for RF only have an increase in mortality rates compared with patients who are dual seronegative. RF positivity could be an indicator of inflammation that requires pharmacologic treatment to decrease mortality rates.
引用
- Brooks RT, Achenbach SJ, Kronzer VL, et al. Impact of Dual Rheumatoid Factor and Anticitrullinated Protein Antibody Seropositive, Single Seropositive, and Seronegative Rheumatoid Arthritis on Outcomes. Arthritis Care Res (Hoboken). 2026. PMID: 41556559. doi:10.1002/acr.80009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。